Key Points - Adjusted earnings per share (EPS) of $3.49 in Q2 2025 beat analyst estimates by 2.65%, while GAAP revenue in Q2 2025 was just shy of expectations. Free cash flow (non-GAAP) rose 59% to ...

Capital allocation has always been a high-stakes endeavor, but several market realities are forcing a reckoning for limited ...

Applying the yardstick that investment sage Warren Buffett regards as the best single measure of market valuation — stock market capitalisation relative to GDP — US equities are at historic record ...

Government officials managing the state budget say they don’t know how much taxpayer money the state of Maryland allocates to ...

Intentional, inclusive strategies can dramatically improve the odds of successful change adoption — and the confidence that ...

ECU's Stonecipher School of Business launches a B.S. in business administration with a concentration in human resource ...

AppLovin's AI-powered Axon platform drives scalable, high-margin ad revenue with strong FCF growth. Learn why APP stock is a ...

Tech companies are slashing jobs and pouring billions into AI, but early results suggest the payoff may fall short of the ...

True transformation in high-risk industries heavily reliant on supply chains depends not just on technology but on people. Geoff Goodman, ...

At sunrise in Kampala, as charcoal fires light and boda bodas hit the road, the air begins to thicken with a deadly mix of ...

The rising demand for robust African research presents anyone considering a doctoral degree with an extraordinary opportunity to be part of something truly transformative.

The combined company will operate under the name 'ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol ...